Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nitz

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology AssessmentOleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
JAMA Oncology|May 11, 2023
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor-Positive/ERBB2-Positive Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical TrialOleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2022
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast CancerUlrike A Nitz, Oleg Gluz, Sherko Kümmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP TrialNadia Harbeck, Ulrike A Nitz, Matthias Christgen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trialsDonald A Berry, Naoto T Ueno, Marcella M Johnson, et al.
Physical Review Letters|April 22, 2014
Constraints on cosmic strings from the LIGO-Virgo gravitational-wave detectorsJ Aasi, J Abadie, B P Abbott, et al.
Physical Review Letters|December 20, 2014
Improved upper limits on the stochastic gravitational-wave background from 2009-2010 LIGO and Virgo dataJ Aasi, B P Abbott, R Abbott, et al.
Living Reviews in Relativity|February 10, 2017
Prospects for Observing and Localizing Gravitational-Wave Transients with Advanced LIGO and Advanced VirgoB P Abbott, , , et al.
Physical Review. D. (2016)|August 21, 2020
GW150914: First results from the search for binary black hole coalescence with Advanced LIGOB P Abbott, R Abbott, T D Abbott, et al.
Physical Review Letters|July 2, 2016
GW151226: Observation of Gravitational Waves from a 22-Solar-Mass Binary Black Hole CoalescenceB P Abbott, R Abbott, T D Abbott, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology AssessmentOleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
JAMA Oncology|May 11, 2023
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor-Positive/ERBB2-Positive Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical TrialOleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2022
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast CancerUlrike A Nitz, Oleg Gluz, Sherko Kümmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP TrialNadia Harbeck, Ulrike A Nitz, Matthias Christgen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trialsDonald A Berry, Naoto T Ueno, Marcella M Johnson, et al.
Physical Review Letters|April 22, 2014
Constraints on cosmic strings from the LIGO-Virgo gravitational-wave detectorsJ Aasi, J Abadie, B P Abbott, et al.
Physical Review Letters|December 20, 2014
Improved upper limits on the stochastic gravitational-wave background from 2009-2010 LIGO and Virgo dataJ Aasi, B P Abbott, R Abbott, et al.
Living Reviews in Relativity|February 10, 2017
Prospects for Observing and Localizing Gravitational-Wave Transients with Advanced LIGO and Advanced VirgoB P Abbott, , , et al.
Physical Review. D. (2016)|August 21, 2020
GW150914: First results from the search for binary black hole coalescence with Advanced LIGOB P Abbott, R Abbott, T D Abbott, et al.
Physical Review Letters|July 2, 2016
GW151226: Observation of Gravitational Waves from a 22-Solar-Mass Binary Black Hole CoalescenceB P Abbott, R Abbott, T D Abbott, et al.
Pageof 10